侧隔膜中的HCN通道抑制剂ZD7288减弱了甲基胺诱导的行为敏感化和复发
Shishi Lai1, Wenpei Zhang2, Cailing Wang3
1Yunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, 650091, China; Shenzhen Key Laboratory of Drug Addiction, the Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China; Shenzhen Neher Neural Plasticity Laboratory, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China; Yunnan University, Kunming, 650091, China; Southwest United Graduate School, Kunming, 650092, China.
使用ZD7288准横隔膜 (LS) 中的高极化激活的循环核酸门 (HCN) 通道,可以减少甲基胺成行为. 这种方法使神经元活动正常化,而不会影响自然奖励.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 药物成涉及边缘电路失调,侧面隔膜 (LS) 对于奖励和敏感性至关重要.
- 慢性甲基胺 (METH) 在LS中高调高极化激活的循环核酸门 (HCN) 通道,但它们的治疗向尚未被探索.
研究的目的:
- 为了研究抑制LS HCN通道对METH使用障碍的治疗潜力.
- 评估ZD7288对METH诱导的行为和神经元活动的影响.
主要方法:
- 在小鼠中用HCN通道抑制剂ZD7288 (局部和全身) 进行药理管理.
- 评估METH诱导的记忆检索,运动器官敏感化,自我管理和提示诱导的恢复.
- 在LS中测量神经元刺激性和评估自然奖励处理.
主要成果:
- ZD7288减弱了METH诱导的记忆检索和运动器敏感化,而不会影响记忆获取.
- 抑制剂降低了METH自给收购和提示诱导的恢复.
- 这些效应与LS中正常化的METH诱导的神经元过敏反应相关,而不会影响自然奖励.
结论:
- LS HCN通道是METH使用障碍的潜在治疗点.
- 通过使奖励和敏感化途径正常化,抑制这些道为治疗成提供了一个有希望的策略.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Release or Uptake
Desensitization and Tachyphylaxis
Drug Abuse and Addiction: Pharmacological Phenomena


